v3.26.1
CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY - USD ($)
$ in Thousands
Adjustment
Common Stock
Adjustment
Additional Paid-in Capital
Common Stock
Additional Paid-in Capital
Retained Earnings
Accumulated Other Comprehensive Income (Loss)
Total
Beginning Balance at Dec. 31, 2024     $ 254 $ 49,216 $ 358,704 $ 13,179 $ 421,353
Beginning Balance (in shares) at Dec. 31, 2024     25,402,782        
Shareholders' Equity              
Net income         33,123   33,123
Stock based compensation expense       1,028     1,028
Vesting of restricted stock     $ 1 (1)      
Vesting of restricted stock (in shares)     136,238        
Repurchase of common stock       (31)     (31)
Repurchase of common stock (in shares)     (1,274)        
Other comprehensive loss           (7,592) (7,592)
Dividends declared on common stock         (11,781)   (11,781)
Ending Balance at Jun. 30, 2025     $ 255 50,212 380,046 5,587 436,100
Ending Balance (in shares) at Jun. 30, 2025     25,537,746        
Beginning Balance at Mar. 31, 2025     $ 254 49,645 369,110 8,960 427,969
Beginning Balance (in shares) at Mar. 31, 2025     25,402,782        
Shareholders' Equity              
Net income         16,826   16,826
Stock based compensation expense       599     599
Vesting of restricted stock     $ 1 (1)      
Vesting of restricted stock (in shares)     136,238        
Repurchase of common stock       (31)     (31)
Repurchase of common stock (in shares)     (1,274)        
Other comprehensive loss           (3,373) (3,373)
Dividends declared on common stock         (5,890)   (5,890)
Ending Balance at Jun. 30, 2025     $ 255 50,212 380,046 5,587 436,100
Ending Balance (in shares) at Jun. 30, 2025     25,537,746        
Beginning Balance at Dec. 31, 2025     $ 1,159 138,675 402,684 1,666 544,184
Beginning Balance (in shares) at Dec. 31, 2025     28,817,967        
Shareholders' Equity              
Net income         44,445   44,445
Stock based compensation expense       1,020     1,020
Vesting of restricted stock     $ 2 (2)      
Vesting of restricted stock (in shares)     121,187        
Repurchase of common stock     $ (2) (4,441)     (4,443)
Repurchase of common stock (in shares)     (157,925)        
Other comprehensive loss           (1,741) (1,741)
Dividends declared on common stock         (15,611)   (15,611)
Ending Balance at Jun. 30, 2026 $ (871) $ 871 $ 288 136,123 431,518 (75) 567,854
Ending Balance (in shares) at Jun. 30, 2026     28,781,229        
Beginning Balance at Mar. 31, 2026     $ 286 135,531 417,750 589 554,156
Beginning Balance (in shares) at Mar. 31, 2026     28,660,042        
Shareholders' Equity              
Net income         22,131   22,131
Stock based compensation expense       594     594
Vesting of restricted stock     $ 2 (2)      
Vesting of restricted stock (in shares)     121,187        
Other comprehensive loss           (664) (664)
Dividends declared on common stock         (8,363)   (8,363)
Ending Balance at Jun. 30, 2026 $ (871) $ 871 $ 288 $ 136,123 $ 431,518 $ (75) $ 567,854
Ending Balance (in shares) at Jun. 30, 2026     28,781,229